EX-99.1 2 cmw2290a.htm PRESS RELEASE

Contact: Patrick E. Beans
Chief Financial Officer
402-475-2525

NATIONAL RESEARCH CORPORATION ANNOUNCES SECOND
QUARTER 2006 RESULTS


Company Reports Continuing Growth

LINCOLN, Nebraska (August 1, 2006) — National Research Corporation (NASDAQ: NRCI), a leader in healthcare performance measurement, today announced results for the second quarter ended June 30, 2006.

  Quarterly revenues increased by 49%
  Quarterly net new contracts: $2.1 million
  Quarterly net income up 43%
  Quarterly earnings per share growth equals 47%

        Revenues for the quarter ended June 30, 2006, were $10.7 million compared with revenues of $7.2 million for the same period in 2005. Net income for the quarter ended June 30, 2006, was $1.3 million, or $0.19 per basic and diluted share, compared with net income of $925,000, or $0.13 per basic and diluted share, in the prior-year period. Earnings per share for the quarter ended June 30, 2006, were negatively impacted $.02 as a result of the effect of Statement of Financial Accounting Standards (“SFAS”) No. 123R adopted in the first quarter and would have been $0.21 per share without that effect.

        Revenues for the first half of 2006 were $20.1 million compared with revenues of $14.0 million for the same period in 2005. Net income for the six months ended June 30, 2006, was $2.5 million, or $0.37 per basic and diluted share, compared with $1.6 million, or $0.23 per basic and diluted share, in the prior-year period. Earnings per share for the six months ended June 30, 2006, were negatively impacted $.04 as a result of the effect of the Company’s adoption of SFAS No. 123R and would have been $0.41 per share without that effect.

        Commenting on the results, Michael D. Hays, chief executive officer of National Research Corporation, said, “Our second quarter performance continues the Company’s growth momentum for which I’m very pleased. The matrix I focus on most is our Total Recurring Contract Value which has now risen to $46.1 million, up 42% compared to this time one year ago.”

-MORE-


NRCI Announces Second Quarter Results
Page 2
August 1, 2006

        In closing, Patrick E. Beans, chief financial officer of National Research Corporation, remarked, “The success of our sales expansion efforts continues to produce growth in both revenue and earnings per share while increasing our recurring revenue base. In addition, the acquisition of The Governance Institute on May 30, 2006, will add to the Company’s revenue and earnings going forward.”

        A listen-only simulcast of National Research Corporation’s second quarter 2006 conference call will be available online at www.earnings.com on August 2, 2006, beginning at 11:00 a.m. Eastern time. The online replay will follow approximately an hour later and continue for 30 days.

        National Research Corporation, headquartered in Lincoln, Nebraska, is a leading provider of performance measurement and improvement services to the healthcare industry in the United States and Canada.

        This press release includes “forward-looking” statements related to the Company that can generally be identified as describing the Company’s future plans, objectives or goals. Such forward-looking statements are subject to risks and uncertainties that could cause actual results or outcomes to differ materially from those currently anticipated. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For further information about the factors that could affect the Company’s future results, please see the Company’s filings with the Securities and Exchange Commission.







-MORE-


NRCI Announces Second Quarter Results
Page 3
August 1, 2006

NATIONAL RESEARCH CORPORATION
Unaudited Consolidated Statements of Operations

(In thousands, except per share data)

Three Months Ended
June 30,

Six Months Ended
June 30,

2006
2005
2006
2005

Revenues
    $ 10,663   $ 7,150   $ 20,140   $ 13,746  

Operating expenses:
  
    Direct expenses    4,980    3,073    9,080    5,822  
    Selling, general and administrative    3,042    2,089    6,047    4,274  
    Depreciation and amortization    500    454    971    878  




        Total operating expenses    8,522    5,616    16,098    10,974  





        Operating income
    2,141    1,534    4,042    2,772  

Other income (expense):
  
    Interest income    56    130    138    239  
    Interest expense    (82 )  (101 )  (92 )  (202 )
    Other, net    (10 )  (23 )  (24 )  (28 )





        Total other income (expense)
    (36 )  6    22    9  

        Income before income taxes
    2,105    1,540    4,064    2,781  
        Provision for income taxes    786    615    1,528    1,108  





Net income
   $ 1,319   $ 925   $ 2,536   $ 1,673  





Net income per share, basic
   $ 0.19   $ 0.13   $ 0.37   $ 0.23  




Net income per share, diluted   $ 0.19   $ 0.13   $ 0.37   $ 0.23  





Weighted average shares outstanding:
  
    Basic    6,845    7,122    6,832    7,136  
    Diluted    6,970    7,179    6,938    7,191  

-MORE-


NRCI Announces Second Quarter Results
Page 4
August 1, 2006

NATIONAL RESEARCH CORPORATION
Consolidated Condensed Balance Sheets

(Dollars in thousands)

June 30,
2006

Dec. 31,
2005

ASSETS (Unaudited) (Audited)

Current Assets:
           
    Cash and cash equivalents   $ 575   $ 844  
    Short-term investments    1,677    9,452  
    Accounts receivable, net    6,348    5,495  
    Other current assets    4,214    2,427  


           Total current assets    12,814    18,218  

Net property and equipment
    11,949    11,891  
Other, net    37,112    14,566  



           Total Assets
   $ 61,875   $ 44,675  



LIABILITIES AND SHAREHOLDERS’ EQUITY

Current Liabilities:
  
    Accounts payable and accrued expenses   $ 1,556   $ 2,007  
    Deferred revenue    9,366    5,434  
    Accrued compensation    1,470    1,248  
    Notes payable    4,339    1,471  


           Total current liabilities    16,731    10,160  

Non-current liabilities
    10,072    1,922  



           Total Liabilities
    26,803    12,082  



Shareholders’ Equity:
  
    Common stock, $0.001 par value; 20,000,000 shares authorized;  
      issued 7,810,068 in 2006 and 7,740,571 in 2005;  
      outstanding 6,912,034 in 2006 and 6,845,571 in 2005    8    8  
    Additional paid-in capital    21,359    20,046  
    Retained earnings    24,518    23,360  
    Unearned compensation    (508 )  (433 )
    Accumulated other comprehensive income    447    300  
    Treasury stock    (10,752 )  (10,688 )


           Total shareholders’ equity    35,072    32,593  


           Total Liabilities and Shareholders’ Equity   $ 61,875   $ 44,675  


-END-